Review
doi: 10.1186/cc9997.
Epub 2011 Mar 22.
New treatment options against gram-negative organisms
Affiliations
- PMID: 21457501
- PMCID: PMC3219411
- DOI: 10.1186/cc9997
Item in Clipboard
Review
New treatment options against gram-negative organisms
Crit Care.
2011.
No abstract available
Figures
New antibacterial agents approved in the United States, 1983-2009. From [3] with permission.
Similar articles
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
-
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.Int J Antimicrob Agents. 2005 Dec;26(6):463-72. doi: 10.1016/j.ijantimicag.2005.08.016. Epub 2005 Nov 8. Int J Antimicrob Agents. 2005. PMID: 16280243 Free PMC article.
-
Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management.Pharmacotherapy. 2015 Oct;35(10):949-62. doi: 10.1002/phar.1636. Pharmacotherapy. 2015. PMID: 26497481 Review.
-
Preserving the Dwindling β-lactams-Based Empiric Therapy Options for Gram-Negative Infections in Challenging Resistance Scenario: Lessons Learned and Way Forward.Microb Drug Resist. 2020 Jun;26(6):637-651. doi: 10.1089/mdr.2019.0195. Epub 2019 Dec 17. Microb Drug Resist. 2020. PMID: 31851576 Review.
-
Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.BMC Infect Dis. 2021 May 17;21(1):444. doi: 10.1186/s12879-021-06140-5. BMC Infect Dis. 2021. PMID: 34001022 Free PMC article.
Cited by
-
In vitro activity of cefiderocol against Gram-negative aerobic bacilli in planktonic and biofilm form-alone and in combination with bacteriophages.Sci Rep. 2025 May 16;15(1):17105. doi: 10.1038/s41598-025-01704-w. Sci Rep. 2025. PMID: 40379736 Free PMC article.
-
Screening of compound library identifies novel inhibitors against the MurA enzyme of Escherichia coli.Appl Microbiol Biotechnol. 2021 May;105(9):3611-3623. doi: 10.1007/s00253-021-11272-4. Epub 2021 Apr 16. Appl Microbiol Biotechnol. 2021. PMID: 33860835
-
Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study.Case Rep Infect Dis. 2016;2016:8794696. doi: 10.1155/2016/8794696. Epub 2016 Mar 15. Case Rep Infect Dis. 2016. PMID: 27064923 Free PMC article.
-
Antimicrobial Resistance and Extended-Spectrum Beta-Lactamase Genes in Enterobacterales, Pseudomonas and Acinetobacter Isolates from the Uterus of Healthy Mares.Pathogens. 2023 Sep 8;12(9):1145. doi: 10.3390/pathogens12091145. Pathogens. 2023. PMID: 37764953 Free PMC article.
-
Cephem Potentiation by Inactivation of Nonessential Genes Involved in Cell Wall Biogenesis of β-Lactamase-Producing Escherichia coli.Antimicrob Agents Chemother. 2017 Feb 23;61(3):e01773-16. doi: 10.1128/AAC.01773-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 27956425 Free PMC article.
References
-
- Infectious Diseases Society of America. Bad Bugs, No Drugs. As Antibiotic Discovery Stagnates... A Public Health Crisis Brews. IDSA, Alexandria; 2004.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
